Mechanism of molecular interaction of sitagliptin with human DPP
Dipeptidyl peptidase 4
In silico analysis
Molecular docking
Sitagliptin
Type 2 diabetes mellitus
Journal
Advances in medical sciences
ISSN: 1898-4002
Titre abrégé: Adv Med Sci
Pays: Netherlands
ID NLM: 101276222
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
30
01
2023
revised:
16
06
2023
accepted:
04
10
2023
medline:
24
11
2023
pubmed:
15
10
2023
entrez:
14
10
2023
Statut:
ppublish
Résumé
Dipeptidyl peptidase 4 (DPP Docking studies were conducted using AutoDock Vina, 2D and 3D schematic drawings were obtained using PoseView and PLIP servers, and the DPP The best affinity energy to form the DPP The stable interaction between the sitagliptin ligand and the DPP
Identifiants
pubmed: 37837799
pii: S1896-1126(23)00042-1
doi: 10.1016/j.advms.2023.10.002
pii:
doi:
Substances chimiques
Sitagliptin Phosphate
TS63EW8X6F
Dipeptidyl-Peptidase IV Inhibitors
0
Hypoglycemic Agents
0
Peptides
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
402-408Informations de copyright
Copyright © 2023 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare no conflict of interests.